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ABSTRACT
The E2F1 transcription factor plays key roles in skin homeostasis. In the
epidermis, E2F1 expression is essential for normal proliferation of undifferentiated
keratinocytes, regeneration after injury and DNA repair following UV radiation-induced
photodamage. Abnormal E2F1 expression promotes nonmelanoma skin carcinoma. In
addition, E2F1 must be downregulated for proper keratinocyte differentiation, but the
relevant mechanisms involved remain poorly understood. We show that differentiation
signals induce a series of post-translational modifications in E2F1 that are jointly
required for its downregulation. Analysis of the structural determinants that govern
these processes revealed a central role for S403 and T433. In particular, substitution
of these two amino acid residues with non-phosphorylatable alanine (E2F1 ST/A)
interferes with E2F1 nuclear export, K11- and K48-linked polyubiquitylation and
degradation in differentiated keratinocytes. In contrast, replacement of S403 and
T433 with phosphomimetic aspartic acid to generate a pseudophosphorylated E2F1
mutant protein (E2F1 ST/D) generates a protein that is regulated in a manner
indistinguishable from that of wild type E2F1. Cdh1 is an activating cofactor that
interacts with the anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3
ligase, promoting proteasomal degradation of various substrates. We found that Cdh1
associates with E2F1 in keratinocytes. Inhibition or RNAi-mediated silencing of Cdh1
prevents E2F1 degradation in response to differentiation signals. Our results reveal
novel regulatory mechanisms that jointly modulate post-translational modifications
and downregulation of E2F1, which are necessary for proper epidermal keratinocyte
differentiation.

tightly regulated in tissues composed of undifferentiated
and differentiated cell populations, such as the epidermis
and the central nervous system [4-6]. For example,
E2F1 is more abundant in keratinocyte stem cells and
their undifferentiated, transit amplifying progeny than
in terminally differentiated cells. Overexpression of
E2F1 causes nonmelanoma skin carcinoma. Conversely,
keratinocyte differentiation requires E2F1 downregulation,
which occurs through transcriptional and post-translational
mechanisms [7]. Physiological activation of keratinocytes
to regenerate the wounded epidermis is associated with
E2F1 upregulation, and is severely impaired in the absence
of this transcription factor [8]. Due to their chronic
exposure to solar UV radiation, epidermal keratinocytes
have developed efficient mechanisms for DNA repair to

INTRODUCTION
The E2F family of transcription factors plays
important roles in myriad physiological processes.
The more widely characterized functions of this family
include their regulatory roles in cell cycle progression
and tumourigenesis, although it is now well established
that E2F proteins also modulate such diverse processes
as metabolism, apoptosis, and differentiation [1, 2]. In
mammals, eight E2F and three DP proteins have been
described [3], but the elucidation of their specific functions
has been complicated in part due to their functional
redundance under certain conditions.
E2F1 was the first member of this family identified,
and is ubiquitously expressed, although its abundance is
www.impactjournals.com/oncotarget

4977

Oncotarget

avoid carcinogenic transformation, which rely on E2F1
and various other factors [9, 10].
The importance of post-translational modifications
for E2F1-regulated functional outcomes has been
extensively studied in the context of responses to DNA
damage in normal epidermal keratinocytes and various
tumour cell types. Several studies have identified serine
phosphorylation, arginine methylation and lysine
acetylation in E2F1 as key events triggered by formation
of DNA strand breaks [1, 10]. Less well understood
are the pathways and mechanisms that regulate E2F1
post-translationally during physiological events,
such as keratinocyte differentiation. In the epidermis,
keratinocytes are induced to differentiate in response to
several stimuli, which include Ca2+-activated pathways and
Notch signalling [7, 11]. These events can be recapitulated
in cultured primary keratinocytes by elevating the
extracellular Ca2+ concentration from ~0.05 to ≥ 0.1 mM.
Under these conditions, E2F1 undergoes p38β-dependent
phosphorylation at S403 and T433 and ubiquitylation,
culminating with its degradation [7, 12, 13]. It is well
established that E2F1 degradation is essential for proper
keratinocyte differentiation [7, 12, 13]. However, the
detailed molecular mechanisms that modulate E2F1 levels
during differentiation have not been explored. We now
show a specific, unique role of residues S403 and T433
in modulating E2F1 changes in subcellular localization,
as well as K11- and K48-linked ubiquitylation, necessary
for proper keratinocyte differentiation in response to Ca2+
stimulation.

to 14-3-3-τ, which in turn decreases E2F1 ubiquitylation
and degradation [15]. To determine the role of these
two residues during differentiation, we exogenously
expressed wild type, S31A or S364A E2F1 in primary
mouse keratinocytes, and assessed their abundance 24 h
after induction of differentiation by culture in medium
containing 1.0 mM Ca2+ (“High Ca2+ medium”). Both
mutant and wild type E2F1 showed similar decreases of
45-60% in response to Ca2+ (Figure 1).
Several E2F1 lysine residues can be acetylated,
methylated and/or neddylated. Whereas acetylation of
K117, K120 and K125 upon DNA damage increases
E2F1 stability [16], their neddylation increases E2F1
degradation in the absence of DNA damage [17].
However, we observed that mutation of these three lysines
to arginine to produce the mutant E2F1 “KTR” did not
alter degradation during differentiation (Figure 1). Similar
susceptibility to differentiation-induced degradation was
observed in a mutant E2F1 K185R (Figure 1), in which
methylation and neddylation, known to regulate stability,
are precluded [17].
Methylation of R111 and R113 modulates the proapoptotic responses to E2F1, and Arg-to-Lys mutation of
these residues reportedly yields a mutant “E2F1 RDK”
protein with increased stability in osteosarcoma cells [18].
We observed that the levels of this mutant also decreased
by about 70% upon differentiation (Figure 1). Finally,
although phosphorylation of S332, S337 and S375 is
important for E2F1 association with the retinoblastoma
protein, transcriptional activity and protection from
degradation in tumour cell lines, these residues are also
dispensable for E2F1 degradation in differentiating
keratinocytes (Figure 1). Our studies also confirmed
the previously reported essential role of S403 and T433
in mediating E2F1 degradation during differentiation
[7], as mutation of one or both of these residues to
alanine yielded E2F1 proteins resistant to Ca2+ -induced
degradation (Figure 1). We similarly examined the changes
in steady-state levels of wild type and mutant E2F1
proteins following DNA damage induced by etoposide
(Supplementary Figure S1). Etoposide treatment increased
the abundance of wild type, K185R and RDK E2F1
proteins, irrespective of the differentiation status of the
keratinocytes. In contrast, the abundance of E2F1 S31A
remained unaltered in etoposide-treated cells, indicating
that S31 is essential for a normal response to etoposide
damage in both differentiated and undifferentiated cells.
Significantly, etoposide also increased the abundance of
the double S403A/T433A E2F1 mutant (hereafter termed
E2F1 ST/A), consistent with the notion that S403 and
T433 are not required for E2F1 stabilization upon DNA
damage. Together, our studies indicate that the molecular
determinants that regulate E2F1 abundance during
epidermal differentiation are distinct from those activated
during DNA damage.

RESULTS
Distinct molecular determinants of E2F1
stability during differentiation and DNA damage
E2F1 has a relatively short half-life that ranges
between 1 h and 4 h in most cell types examined todate, and changes in its stability can rapidly occur to
allow cell responses to various stresses. For example,
E2F1 is stabilized in response to DNA damage caused
pharmacologically, by UV or ionizing radiation. This
phenomenon has been widely characterized, and the role
of several key E2F1 residues implicated in stabilization
is well established [1]. However, whether those same
residues are also involved in regulating E2F1 turnover
during terminal differentiation is not known. We addressed
this question in primary epidermal keratinocytes, in
which E2F1 is rapidly degraded upon induction of
differentiation [7].
DNA damage in epidermal keratinocytes and
other cell types induces ATM and/or ATR-mediated
phosphorylation of S31, as well as Chk2-mediated
phosphorylation of S364 in human E2F1, resulting in
increased stability [14, 15]. Phosphorylated S31 binds
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Role of nuclear export in differentiation-induced
E2F1 degradation

Ca2+, the levels of E2F1-ST/A-NES remained unaltered
(Figure 3B). Thus, these observations demonstrate that
nuclear export depends on intact S403 and T433 residues,
but that it is not sufficient to promote E2F1 degradation in
response to differentiation in keratinocytes.

We have previously shown that E2F1 undergoes
nucleocytoplasmic shuttling, and that it exhibits a net
nuclear CRM1-dependent export into the cytoplasm
in differentiating keratinocytes. The latter is necessary
for degradation, as leptomycin B inhibition of CRM1
results in E2F1 stabilization and constitutive nuclear
localization [12, 19]. Consistent with this notion, analyses
of the subcellular distribution of the E2F1 mutants
described above, and which exhibited differentiationinduced degradation, revealed nuclear export that was
indistinguishable from that observed with the wild type
protein (Figure 2 and Supplementary Figure S2). In
contrast, the single S403A and T433A E2F1 forms, as
well as E2F1 ST/A, remained nuclear in differentiated
cells (Figure 2, Supplementary Figure S2) Given the
complexity of E2F1 regulatory mechanisms, we wished
to further investigate if nuclear export was the principal
pathway involved in its Ca2+-induced degradation. To
this end, we generated wild type and ST/A mutants that
also contained the leucine-rich consensus nuclear export
sequence (NES) from the simian virus 40 large T antigen
(LPPLERLTL) at the C-terminus. Addition of this NES to
both E2F1 forms yielded proteins that were constitutively
cytoplasmic, irrespective of the differentiation status of the
keratinocytes (Figure 3A). However, whereas E2F1-NES
exhibited a marked decrease in abundance in response to

Potential role of S403 and T433 phosphorylation
in regulation of E2F1 subcellular localization
The above observations prompted us to examine if
phosphorylation of S403 and/or T433 might play additional
roles in E2F1 turnover. To address this possibility, we
generated pseudophosphorylated E2F1 mutant forms,
in which S403, T433 or both were substituted with
aspartic acid. We initially compared the mobility of
these mutant proteins with that of wild type E2F1 on
denaturing polyacrylamide gels. Several wild type E2F1
species were evident in lysates from both differentiated
and undifferentiated keratinocytes, which collapsed
into a single band upon treatment with λ phosphatase,
indicating that E2F1 is phosphorylated at one or more
residues in these cells (Figure 4A). In undifferentiated
cells, substitution of S403 by either alanine or aspartic
acid gave rise to mutant E2F1 proteins that migrated with
similar mobility to that of unphosphorylated wild type
E2F1. Treatment with λ phosphatase did not appreciably
alter the mobility of E2F1 S403A and S403D (Figure 4A),
indicating that S403 is likely phosphorylated in these
cells. Substitution of T433 by alanine or aspartic acid

Figure 1: S403 and T433 mediate E2F1 degradation during keratinocyte differentiation. Vectors encoding V5-tagged wild

type (WT) or the indicated E2F1 mutants were transfected in undifferentiated keratinocytes. Twenty-four hours after transfection, cells were
treated with cycloheximide (CHX, 100 μg/ml), and 30 min later the culture medium was replaced with Low Ca2+ or High Ca2+ medium
supplemented with CHX. Cell lysates were prepared 2.5 h later and analyzed by immunoblot for the indicated proteins, using anti-V5
antibodies, or γ-tubulin, as loading control. The histograms represent normalized densitometric quantification of each E2F1 protein (mean
+ SEM), and are expressed as the percentage of a given E2F1 form relative to its abundance in Low Ca2+ medium, which is set at 100%.
The asterisks indicate P<0.05 (ANOVA).
www.impactjournals.com/oncotarget
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gave rise to an E2F1 form with intermediate mobility
between the wild type and the S403 mutant, and which
further collapsed to a single species in the presence of λ
phosphatase (Figure 4A). λ phosphatase treatment had no
effect on the mobility of E2F1 ST/A or ST/D. However,
the latter exhibited lower mobility than the former, likely
related to the overall charge of the protein under these
conditions (Figure 4A). Similar results were obtained
using lysates prepared from differentiated keratinocytes
in the presence and absence of λ phosphatase (Figure 4A).
Next, we examined if E2F1 pseudophosphorylation is
sufficient to mediate nuclear export in response to Ca2+.

We observed that substitution of S403, T433 or both by
aspartic acid produced mutant proteins predominantly
localized to the nucleus in undifferentiated cells, and
which were efficiently redistributed to the cytoplasm upon
differentiation in a manner that was indistinguishable from
that of wild type E2F1 (Figure 4B).

Differentiation-specific role of S403 and T433
regulation of E2F1 stability
To better understand how phosphorylation might
modulate E2F1 turnover, we measured the apparent

Figure 2: S403 and T433 are required for E2F1 nuclear export during keratinocyte differentiation. Undifferentiated
keratinocytes were transfected with vectors encoding V5-tagged wild type (WT) or the indicated E2F1 mutant proteins. Four hours after
transfection, the culture medium was replaced with Low Ca2+ or High Ca2+ medium, and the cells were processed for immunofluorescence
microscopy 24 h later, using anti-V5 antibodies. DNA was visualized with Hoechst 33342. The values in the histograms represent the
percentage of cells (mean + SEM, n=3) that exhibited nuclear (N) or cytoplasmic (C) E2F1 distribution. The asterisks indicate P<0.05
relative to values in the corresponding subcellular compartments in Low Ca2+ medium (ANOVA). Bar, 16 μm.
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Link between E2F1 S403/T433 phosphorylation
and ubiquitylation

half-life (t½) of exogenously expressed wild type, S403
and T433 mutants in undifferentiated keratinocytes. The
t½ of wild type E2F1 was about 74 min, and was not
significantly different from the t½ of the S403D, T433D,
ST/D and ST/A mutants (Figure 5A). Similar experiments
using differentiated keratinocytes revealed a ~16%-47%
decrease in apparent t½ of wild type, S403D, T433D and
ST/D mutants in response to Ca2+, as compared to their
t½ in undifferentiated cells. In stark contrast, E2F1 ST/A
was remarkably stable, with a t½>240 min, which is at
least 4-fold greater than the other E2F1 proteins examined
(Figure 5B). Thus, S403 and T433 phosphorylation
appears to be involved in E2F1 turnover in keratinocytes,
but only upon differentiation of these cells.

E2F1 undergoes proteasomal degradation
following ubiquitylation, and increases in its stability
have been associated with decreased ubiquitylation
[14]. Therefore, we began to characterize the patterns
of E2F1 ubiquitylation in keratinocytes. We transfected
cells with plasmids encoding wild type V5-tagged E2F1
together with hemagglutinin (HA)-tagged ubiquitin, and
isolated nuclear and cytoplasmic fractions following
a 24-h interval of culture in High-Ca2+ medium in the
presence of the proteasomal inhibitor MG132, to prevent
E2F1 degradation. HA-immunecomplexes were isolated

Figure 3: Effect of constitutive nuclear export on E2F1 abundance in differentiating keratinocytes. A. Undifferentiated
keratinocytes were transfected with vectors encoding V5-tagged wild type (WT) or the indicated E2F1 mutant proteins. Four hours after
transfection, the culture medium was replaced with Low Ca2+ or High Ca2+ medium, and the cells were processed for immunofluorescence
microscopy 24 h later, using anti-V5 antibodies. DNA was visualized with Hoechst 33342. B. Cells transfected as described in (A) were
cultured for 24 h in Low Ca2+ medium. Cycloheximide was added (100 μg/ml), and 30 min later the cells were cultured for 2.5 h in Low Ca2+
or High Ca2+ medium supplemented with cycloheximide. Cell lysates were prepared and analyzed by immunoblot with antibodies against
V5 or γ-tubulin, used as loading control. The histograms represent normalized densitometric quantification of each E2F1 protein (mean +
SEM, n=3), and are expressed as the percentage of a given E2F1 form relative to its abundance in Low Ca2+ medium, which is set at 100%.
The asterisks indicate P<0.05 (ANOVA).
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from these fractions and the presence of V5-tagged E2F1
species was assessed. We were able to detect ubiquitylated
E2F1 in both nuclear and cytoplasmic fractions. Further,
ubiquitylated E2F1 was also present in whole-cell lysates
from keratinocytes treated with leptomycin B, suggesting
that ubiquitylation of E2F1 in differentiated keratinocytes
does not require nucleocytoplasmic shuttling (Figure 6A).
Similarly, we observed the presence of ubiquitylated E2F1
KTR and K185R mutants, which lack lysine residues
needed for ubiquitylation in other cell types, irrespective
of the differentiation status of the keratinocytes
(Supplementary Figure S3). These observations indicate
that several of the fourteen lysines present in human E2F1

are ubiquitylated in these cells, and that K117, K120,
K125 and K185 are not essential for E2F1 ubiquitylation
during keratinocyte differentiation.
We also investigated the role of S403 and T433 in
E2F1 ubiquitylation. For these experiments, we transfected
keratinocytes with plasmids encoding V5-tagged wild
type or ST/A E2F1, together with HA-tagged ubiquitin,
and again isolated HA-ubiquitin immunoprecipitates from
undifferentiated and from differentiated cells. We observed
the presence of multiple ubiquitylated wild type and ST/A
E2F1 species in lysates from both undifferentiated and
differentiated keratinocytes (Figure 6B), indicating that
substitution of S403 and T433 with non-phosphorylatable

Figure 4: Characterization of pseudophosphorylated E2F1 mutant proteins. A. Undifferentiated keratinocytes were transfected

with vectors encoding V5-tagged wild type (WT) or the indicated E2F1 mutant proteins. Four hours after transfection, the culture medium
was replaced with Low Ca2+ or High Ca2+ medium. After 24 h, cell lysates were prepared and incubated in the presence or absence of λ
phosphatase (λ PP; 4 U/mg of lysate protein), resolved on denaturing polyacrylamide gels, and analyzed by immunoblot, with antibodies
against V5 or γ-tubulin, used as loading control. The results shown are representative of three experiments. B. Cells transfected as described
in (A) were processed for immunofluorescence microscopy following 24 h of incubation in Low Ca2+ or High Ca2+ medium, using anti-V5
antibodies. DNA was visualized with Hoechst 33342. The values in the histograms represent the percentage of cells (mean + SEM, n=3) that
exhibited nuclear (N) or cytoplasmic (C) E2F1 distribution. The asterisks indicate P<0.05 relative to values in the corresponding subcellular
compartments in Low Ca2+ medium (ANOVA). Bar, 16 μm.
www.impactjournals.com/oncotarget
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alanine did not abrogate the overall capacity of E2F1 to
serve as a substrate for ubiquitylation.
Proteins can have a single ubiquitin added to
one or multiple lysine residues, resulting, respectively
in mono- or multi-ubiquitylation [20]. In addition,
several types of polyubiquitin chains can be added to
substrate proteins, depending on which of the seven
lysines contained in ubiquitin are utilized for linkage.
The resulting modifications can have marked structural
and functional consequences. For example, whereas

K11 and K48 linkages direct ubiquitylated substrates to
proteasomal degradation, ubiquitylation via K63 linkages
can modulate the activity of proteins involved in signal
transduction and DNA damage, rather than degradation
[20]. Therefore, we examined the possibility that S403
and T433 may modulate the type of ubiquitin linkages on
E2F1. To this end, we first co-expressed in undifferentiated
keratinocytes wild type or ST/A E2F1, together with HAtagged wild-type ubiquitin or ubiquitin mutants in which
all lysines were replaced by arginines, with the exception

Figure 5: S403 and T433 regulate E2F1 protein half-life in differentiated keratinocytes. Undifferentiated keratinocytes were
transfected with vectors encoding V5-tagged wild type (WT) or the indicated E2F1 mutant proteins. Twenty-four hours after transfection,
the culture medium was replaced with Low Ca2+ (panel A) or High Ca2+ (Continued )
www.impactjournals.com/oncotarget
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Figure 5: (Continued ) S403 and T433 regulate E2F1 protein half-life in differentiated keratinocytes. Undifferentiated
keratinocytes were transfected with vectors encoding V5-tagged wild type (WT) or the indicated E2F1 mutant proteins. Twenty-four hours
after transfection, the culture medium was replaced with High Ca2+ (panel B) medium, followed by addition of cycloheximide (100 μg/
ml, final). Cell lysates were prepared from replicate samples at the indicated times thereafter, and analyzed by immunoblot using anti-V5
antibodies, to detect E2F1, or γ-tubulin, used as loading control. Representative blots for each E2F1 protein are shown. The graphs represent
the densitometric quantification of E2F1 protein levels (mean ± S.D., n=3) calculated from experiments conducted on three independent
keratinocyte isolates, and are expressed as a percent of levels measured at t=0, set to 100%. Decay curves were used to calculate the
apparent half-life of each E2F1 protein (t½), showed on its corresponding graph. For each plot, the decay curve for wild type E2F1 is shown
in red, for comparison. The asterisks indicate P<0.05 relative to t½ of wild type E2F1 (ANOVA).

of K11, K48 or K63. These ubiquitin mutants enhance the
formation of polyubiquitin chains containing, respectively,
K11, K48 or K63 linkages [21]. We then isolated HA
immune complexes and probed them for the presence
of V5-tagged E2F1 proteins. In HA immunoprecipitates
isolated from undifferentiated keratinocyte lysates, we
observed ubiquitylation associated with K11, K48 and K63
www.impactjournals.com/oncotarget

linkages in both wild type and ST/A E2F1 (Figure 6C).
This indicates that E2F1 polyubiquitylation involving K11,
K48 and K63 linkages in undifferentiated keratinocytes
does not require S403 and T433. Similar experiments were
conducted with lysates from differentiated keratinocytes,
but with different outcomes. Although we readily observed
the presence of K11 and K48 ubiquitin-modified wild
4984

Oncotarget

type E2F1, the abundance of K63-linked ubiquitylation
appeared to be proportionally lower (Figure 7A and 7B).
Notably, E2F1 ST/A ubiquitylation through K63 linkages
was readily detected, but little or no detectable K11- and

K48-associated modifications were observed (Figure 7A).
To further explore a potential role of S403 and T433
phosphorylation in E2F1 ubiquitylation in differentiated
cells, we conducted analogous experiments with the

Figure 6: E2F1 ubiquitylation in keratinocytes. A. Undifferentiated keratinocytes were transfected with vectors encoding wild-type

V5-tagged E2F1 and HA-tagged ubiquitin. Twenty-four hours later, MG132 (10 μM, final) was added to the culture medium, followed
3 h later by leptomycin B (LMB, 10 ng/ml, final) or ethanol (vehicle). Cultures were incubated in the presence of both drugs for 30 min,
at which time the Ca2+ concentration was adjusted to 1.0 mM. Lysates containing whole-cell, nuclear (N) or cytoplasmic (C) fractions
were prepared 2.5 h later, HA-ubiquitin immunecomplexes were isolated, resolved by denaturing gel electrophoresis, and analyzed with
anti-V5 antibodies to detect ubiquitylated V5-tagged E2F1. Antibodies against β-tubulin or lamin A/C were used to verify the purity of the
fractionated extracts and as loading controls. B. Undifferentiated keratinocytes were transfected with vectors encoding HA-tagged ubiquitin
and V5-tagged wild type or ST/A E2F1, cultured in Low (-) or High (+) Ca2+ medium, as indicated, and treated with MG132 as in panel
(A). HA or unrelated IgG immunecomplexes were isolated from whole-cell lysates and analyzed by immunoblot with anti-V5 antibodies.
The abundance of exogenous E2F1 proteins in the lysates was analyzed by immunoblot, using γ-tubulin as loading control. The asterisk
indicates the IgG heavy chain. C. Keratinocytes cultured in Low Ca2+ medium were transfected with vectors encoding the indicated V5tagged E2F1 and HA-tagged ubiquitin proteins. Twenty-four hours after transfection, cells were incubated in the presence of MG132 (10
μM, final) for 6 h. Cell lysates were prepared and HA or unrelated IgG immunecomplexes were isolated and analyzed by immunoblot with
anti-V5 antibodies. The abundance of exogenous E2F1 and HA-ubiquitin-containing proteins in the lysates was analyzed by immunoblot,
using γ -tubulin as loading control. Ubn-E2F1 indicates ubiquitylated V5-tagged E2F1 proteins. All results shown are representative of three
replicate experiments conducted with independent cell isolates.
www.impactjournals.com/oncotarget
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Figure 7: S403 and T433 regulate K11- and K48-linkage ubiquitylation of E2F1 in differentiated keratinocytes.

Keratinocytes cultured in Low Ca2+ medium were transfected with vectors encoding wild type or ST/A V5-tagged E2F1 (Panel A), wild
type or ST/D V5-tagged E2F1 (Panel B) together with plasmids encoding the indicated HA-tagged ubiquitin proteins. After 4 h, the culture
medium was replaced with High Ca2+ medium, and cells were cultured for 18 h, followed by incubation in the presence of MG132 (10 μM,
final) for 6 h. Cell lysates were prepared and HA immunecomplexes were isolated and analyzed by immunoblot with anti-V5 antibodies.
The abundance of exogenous E2F1 and HA-ubiquitin-containing proteins in the lysates was analyzed by immunoblot, using γ-tubulin as
loading control. Ubn-E2F1 signifies ubiquitylated V5-tagged E2F1 proteins, and the asterisk shows the position of the IgG heavy chain. All
results shown are representative of at least three replicate experiments conducted with independent cell isolates.
www.impactjournals.com/oncotarget
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pseudophosphorylated mutant E2F1 ST/D, and observed
ubiquitylation in the presence of wild type, K11, K48 and
K63 ubiquitin, similar to wild type E2F1 (Figure 7B).
Together, these data indicate that, upon keratinocyte
differentiation, E2F1 can be polyubiquitylated via K11,
K48 and K63 linkages. However, the addition of ubiquitin
via K11 and K48 linkage might require phosphorylation of
S403 and T433 specifically in differentiated keratinocytes.
In the absence of S403 and T433 phosphorylation, K63-,
but little or no K11- or K48-linked polyubiquitylation is
detected in these cells.

activate APC/C, thereby stabilizing its substrates [26].
For these experiments, we analyzed changes in the
abundance of exogenous V5-tagged E2F1 in response
to hEmi1, as this approach allowed us to better detect
E2F1, while reflecting in parallel changes in endogenous
E2F1. Exogenous expression of hEmi1 induced a slight
increase in the abundance of E2F1 in an asynchronous
population of undifferentiated keratinocytes (Figure 8B).
Notably, hEmi1 prevented the decrease in E2F1 levels
associated with differentiation, and E2F1 levels in cells
cultured in High Ca2+ medium were indistinguishable
from those in undifferentiated keratinocytes (Figure 8B).
hEmi1 was also able to interfere with the reduction in
E2F1 levels in both undifferentiated and differentiated
keratinocytes observed upon overexpression of Cdh1.
To complement these studies, we investigated the effect
of Cdh1 silencing on the regulation of E2F1 using RNA
interference. We observed a three-fold increase in E2F1
levels in undifferentiated keratinocytes treated with Cdh1targeting siRNA, which was unaffected by induction of
differentiation following Ca2+ treatment (Figure 8C).
Together, our observations are consistent with the notion
that Cdh1 is a major contributor to E2F1 degradation
during epidermal keratinocyte differentiation.

Role of Cdh1 in E2F1 degradation upon
induction of keratinocyte differentiation
E2F1 is the target of multiple ubiquitin E3 ligases,
which regulate its turnover. For example, the anaphase
promoting complex/cyclosome E3 ligase activated by
Cdc20 (APC/CCdc20) and SCFSkp2, respectively mediate
E2F1 degradation during prometaphase and the S/G2
phases of the cell cycle [22, 23]. Recently, activation of
APC/C by Cdh1 was shown to mediate E2F1 degradation
via K11 linkage-specific ubiquitylation in M and early
G1 phases, times during which Cdc20 is not present
[24]. Significantly, induction of differentiation in
human keratinocytes is accompanied by downregulation
of CDC20 and SKP2 expression, with concomitant
upregulation of FZR1 transcripts, which encode Cdh1
[25]. Thus, we reasoned that Cdh1 might be a reasonable
candidate to participate in E2F1 degradation during
keratinocyte differentiation. These considerations
prompted us to first investigate whether Cdh1 interacts
with E2F1 in keratinocytes. To this end, we exogenously
expressed wild type V5-tagged E2F1 together with FLAGtagged Cdh1 in undifferentiated keratinocytes, or in cells
that were induced to differentiate by culture in High Ca2+
for 24 h. We were able to detect E2F1 in Cdh1 immune
complexes in cells cultured both in Low and High Ca2+
medium (Figure 8A). We conducted similar experiments
to investigate if the lower levels of E2F1 ST/A K11linked ubiquitylation in differentiated keratinocytes were
associated with a decreased ability of this mutant protein to
bind Cdh1-containing complexes. We were able to detect
E2F1 ST/A in Cdh1 immunoprecipitates isolated from
both undifferentiated and differentiated keratinocytes.
Thus, although S403 and T433 are dispensable for Cdh1
association with E2F1, they appear to be functionally
limiting for K11-linked polyubiquitylation and
susceptibility to degradation specifically in differentiated
cells (Figure 8A).
To determine the functional significance of the
E2F1-Cdh1 interactions, we next investigated the
consequences on the abundance of wild type E2F1
following inhibition of Cdh1 activity. To this end, we
expressed in keratinocytes the F-box protein hEmi1,
which can bind to Cdh1 and interfere with its ability to
www.impactjournals.com/oncotarget

DISCUSSION
One of the most important questions in the biology
of E2F1 is how it is differentially regulated in response
to a wide and complex variety of physiological stimuli,
such as differentiation signals. E2F1 is downregulated
to allow proper entry into quiescence and expression of
differentiation markers in the epidermis [12, 13]. Our
studies now describe a multifactorial mechanism of
E2F1 degradation during keratinocyte differentiation that
involves coordinate changes in subcellular localization
and ubiquitylation patterns, and in which S403 and T433
play key modulatory roles.
E2F1 has a relatively rapid turnover, but
several residues located in the N-terminal half of this
protein participate in its stabilization and escape from
proteasomal degradation in response to DNA damage.
Specifically, post-translational modifications of S31,
K107, K120, K125, K185, R111 and R113 collectively
increase E2F1 stability under these circumstances [1]. In
keratinocytes, E2F1 also participates in repair of DNA
photodamage induced by UV radiation through various
mechanisms, including association with hHR23 proteins
involved in nuclear excision repair [9]. Under these
conditions, hHR23 proteins bind to E2F1 and protect
it from proteasomal degradation. Significantly, E2F1
ST/A and E2F1 deletion mutants lacking S403 and T433
can bind to hHR23A and become stabilized upon UV
irradiation in undifferentiated keratinocytes ([9]; Singh
and Dagnino, unpublished observations), indicating that
the regulation of E2F1 turnover upon DNA damage and
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Figure 8: Cdh1 interacts with E2F1 and promotes its degradation in differentiating keratinocytes. A. Keratinocytes

cultured in Low Ca2+ medium were transfected with vectors encoding FLAG-tagged Cdh1 and V5-tagged E2F1. After 4 h, the cells were
cultured in Low (-) or High Ca2+ (+) medium for 24 h. Cell lysates were prepared and subjected to immunoprecipitation with anti-FLAG
antibodies. The immune complexes were analyzed by immunoblot with anti-V5 antibodies, to detect E2F1. Samples of the lysates were
also analyzed by immunoblot with the indicated antibodies. B. Keratinocytes were transfected with vectors encoding V5-tagged E2F1, in
the presence or absence of vectors encoding FLAG-tagged Cdh1 and myc-tagged hEmi1, as indicated. Twenty-four hours later, the cells
were treated with cycloheximide (100 μg/ml, final) and the culture medium was replaced 30 min later with Low Ca2+ (-) or High Ca2+
medium. Keratinocyte lysates were prepared 3 h later and analyzed by immunoblot with the indicated antibodies. The histograms represent
quantification of E2F1 proteins (mean + SEM, n=3), relative to E2F1 abundance in Low Ca2+ medium in the absence of exogenous Cdh1
and hEmi1, which is set at 100%. The asterisks indicate P<0.05 relative to E2F1 levels in cells cultured in Low Ca2+ medium without other
exogenous proteins, except where otherwise indicated (ANOVA). C. Undifferentiated keratinocytes were sequentially transfected with
control, non-targeting (NT) or Cdh1-targeting siRNAs, followed by transfection with vectors encoding V5-tagged E2F1, as described in
Materials and Methods. Cells were treated with CHX and harvested for protein analysis as described in (B). The histograms represent E2F1
levels (mean + SEM, n=3), relative to those in cells cultured in Low Ca2+ medium in the presence of NT siRNA, which is set at 100%.
Asterisks indicate P<0.05 relative to E2F1 levels in cells cultured in Low Ca2+ medium (ANOVA).
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differentiation proceed through distinct mechanisms.
Significantly, none of the residues involved in E2F1
stabilization following DNA damage are required for
E2F1 downregulation during keratinocyte differentiation,
which instead depends on the integrity of S403 and
T433. This emphasizes the clear distinction between
mechanisms activated in response to physiological and
pathological signals. E2F1 undergoes nucleocytoplasmic
shuttling in undifferentiated keratinocytes and other cell
types, although the balance of these movements favours
a predominantly nuclear localization at steady-state [19].
Upon induction of differentiation, E2F1 is excluded from
the nucleus and retained in the cytoplasm in keratinocytes
and hippocampal neurons [12, 27]. Based on the ability
of wild type and phosphomimetic E2F1 ST/D, but not
E2F1 ST/A, to respond to Ca2+, we propose that such
nucleocytoplasmic translocation is potentially dependent
on phosphorylation of S403 and T433. Our data also
show that nuclear export does not require residues
involved in E2F1 responses to DNA damage. However,
nuclear export is not sufficient for E2F1 degradation
during differentiation, as evidenced by the stability of the
constitutively cytoplasmic E2F1 mutant ST/A-NES. Thus,
multiple factors are necessary for efficient degradation of
E2F1 in response to differentiation signals in epidermal
cells.
E2F1 stability and transcriptional activity can be
modulated through various types of ubiquitin linkages.
In differentiated and in undifferentiated keratinocytes,
we observed evidence of K11- K48- and K63-linked
polyubiquitylation, in agreement with similar findings
reported for various tumour cell lines [24, 28, 29].
Polyubiquitylation via K63 linkages does not appear
to target E2F1 for proteasomal degradation, but rather
decreases its transcriptional activity [29]. During the G1/S
transition and in S phase, K63-linked polyubiquitin chains
are removed from E2F1 by the deubiquitylating enzyme
UCH37. This modification increases E2F1 transcriptional
activity, resulting in increased expression of target genes
that promote cell proliferation [29]. Similarly, following
DNA damage, removal of K63-linked polyubiquitin
chains activates transcription of pro-apoptotic genes [29].
Our data show that K63-linked ubiquitin modifications
are present in keratinocytes, irrespective of their
differentiation status. Given that this modification was
present in wild type, ST/A and ST/D E2F1 proteins, our
data indicate that S403 and T433 do not determine the
susceptibility of E2F1 for K63-linked polyubiquitylation.
An important area for future research will be to determine
the role of K63-linked polyubiquitylation of E2F1 during
keratinocyte differentiation and entry into quiescence.
E2F1 ubiquitylation via K11 and K48 linkages is
required for proteasomal degradation. In addition, posttranslational modifications on E2F1 that subsequently
alter its ubiquitylation patterns regulate both its cell cycle
phase-specific degradation and its stabilization during
www.impactjournals.com/oncotarget

DNA damage [1, 30]. E2F1 degradation at the onset of S/
G2 is achieved through the action of several E3 ubiquitin
ligases. Specifically, SCFSkp2 and Cdc20-activated APC/C
(APC/CCdc20) promote E2F1 turnover during S and M
phase, respectively [22, 31]. This process requires an
intact C-terminal domain in E2F1, and in particular the
region encompassing amino acid residues 363-452 [32,
33]. Although our experiments did not directly test the
role of S403 and T433, these two residues may not be
indispensable for cell cycle-related regulation of E2F1
abundance, given that the t½ we observed for the mutants
E2F1 ST/A and ST/D were fairly similar to the t½ of
the wild type protein in undifferentiated, exponentially
proliferating keratinocytes. In contrast, these two residues
appear to be critical components of the E2F1 degron
implicated in E2F1 proteolysis during keratinocyte
differentiation.
The APC/C complex is a multisubunit E3 ligase
composed of 15 different proteins [34, 35]. Its catalytic
module is composed of APC2 and APC11, and recruits E2
ligases, such as UBE2S, which assembles K11-linked
polyubiquitin chains on client proteins. APC/C requires
association with one of its coactivators, Cdc20 or Cdh1,
to induce substrate ubiquitylation. Cdc20 and Cdh1
recognize and specifically bind myriad substrates,
delivering them to the APC/C complex [34, 35]. In
exponentially proliferating cells, E2F1 is targeted for
degradation by APC/CCdc20 during prometaphase, and by
APC/CCdh1 in the late M and early G1 phases [22, 24].
APC/CCdh1 also regulates the stability of E2F3, E2F7 and
E2F8 during normal cell cycle progression in a variety of
cell types [36, 37].
The regulatory role of Cdh1 goes well beyond cell
cycle progression. In addition to our data implicating Cdh1
in E2F1 degradation during keratinocyte differentiation,
Cdh1 is also required for induction and maintenance
of quiescence in other cell types, cooperating with
retinoblastoma family proteins and cyclin-dependent
kinase inhibitors to maintain cells in the G0/G1 phase [38].
Cdh1 is also necessary to prevent post-mitotic neuron reentry into the cell cycle, thus playing key roles in neuronal
development [38].
Multiple domains in Cdh1 contribute to its
association with several subunits in the APC/C complex,
and these multivalent interactions determine distinct
functional outputs [39]. The ubiquitylation of a substrate
not only depends on its binding to Cdh1, but also on
its relative position and proximity to the K11-linking
machinery [39]. We determined that both wild type
and ST/A E2F1 bind to Cdh1. However, whereas K11
polyubiquitin modifications are readily detected in wild
type E2F1, they are barely present in E2F1 ST/A. It is
possible that phosphorylation of S403 and T433 may
interfere with optimal positioning of E2F1 for subsequent
polyubiquitylation mediated by the APC/CCdh1 complex.
Alternatively, Cdh1 and E2F1 ST/A may associate
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outside the context of APC/C. In this regard, it has been
established that Cdh1 also fulfills APC/C-independent
functions, including promotion of axonal growth in
differentiated neurons, inhibition of the E2 ligase WWP2
with stabilization of PTEN and activation of the Smurf1
ubiquitin ligase to interfere with osteoblast differentiation
[40-42]. E2F1 ST/A also shows deficits in K48-linked
polyubiquitylation, suggesting the involvement of
additional mechanisms that regulate E2F1 proteasomal
degradation. An important area for future research will be
to determine the effect that phosphorylation of S403 and/
or T433 has on E2F1 conformation and its interactions
with APC/CCdh1 and other ubiquitylation complexes. In
our studies, hEmi1-induced inhibition or siRNA-mediated
silencing of Cdh1 interfered with E2F1 downregulation in
differentiating keratinocytes. Given that the latter process
is necessary for normal keratinocyte differentiation,
loss of Fzr, which encodes Cdh1, would be expected to
interfere with normal epidermal morphogenesis in vivo.
The generation and analysis of mice with epidermisrestricted Fzr inactivation will provide future answers to
this important question.
In summary, our results provide mechanistic insight
into a series of complex, differentiation-specific molecular
mechanisms that regulate E2F1 during keratinocyte
maturation via multiple events. These events include
nucleocytoplasmic transport and changes in ubiquitylation
patterns specifically orchestrated through S403 and T433,
and which differ from other mechanisms that regulate
E2F1 turnover in undifferentiated cells.

at timed intervals after CHX addition and analyzed by
immunoblot. For experiments involving proteasomal
inhibition, cells were treated with MG132 (10 μM, final)
for 6 h prior to harvesting. Leptomycin B (LMB, 5 ng/ml,
final) was added to cultures 24 h after transfection and 6 h
prior to cell harvesting. For experiments inducing DNA
damage, keratinocytes were transfected, 24 h later they
were incubated in the presence or absence of etoposide
(150 μM, final), and 8 h after drug addition they were
harvested to prepare cell lysates.

Cdh1 silencing
For experiments using siRNA, cells were transfected
with Lipofectamine 2000 and siRNA (100 nM) for 4 h,
following the manufacturer’s instructions. The medium
was replaced with Low Ca2+ growth medium. Seventytwo hours after siRNA treatment, keratinocytes were
transfected a second time using PEI and plasmids encoding
V5-tagged E2F1 and 21 h later, the cells were treated with
CHX for 30 min. The culture medium was then replaced
with fresh Low or High Ca2+ medium supplemented with
CHX, and the cultures were processed 2.5 h later to obtain
protein lysates. The control siRNA used was the Silencer
Negative Control #1 (AM4611, ThermoFisher Scientific,
Rockford, IL). The sequences of the Cdh1-targeting
siRNAs (siFzr1 siGENOME SMARTpool (M-065289-00,
Dharmacon, GE Healthcare, Lafayette, CO) were:
5’-GCAAUGACGUGUCCCCAUA-3’, 5’-UGGAAC
CACUCUAGUCUAA-3’, 5’-GGUCCAAGCACGC
CAAUGA-3’, and 5’-CGCCAGAGCUUCAGGACGA-3’.

MATERIALS AND METHODS

Reagents and antibodies

Cell culture, transfection and treatments

Reagents and their suppliers were as follows:
Chelex 100 resin from BioRad (142-2832; Mississauga,
ON, Canada), cholera toxin (100) from List Biological
(Campbell, CA, USA), leptomycin B (ALX-380-100) from
Enzo Life Sciences (Plymouth, PA), PEI (25 kDa linear, Cat.
No. 23966) from Polysciences (Warrington, PA). All other
reagents were purchased from Sigma (St. Louis, MO, USA).
The antibodies used were: anti-V5 (R960-25; Invitrogen,
Carlsbad, CA), anti-HA (Y-11) from Santa Cruz (Santa
Cruz, CA), anti-glyceraldehyde 3-phosphodehydrogenase
(GAPDH; ADI CSA 335) from Enzo Life Sciences
(Farmingdale, NY), anti-γ-tubulin (T6557) from Sigma
(St. Louis, MO); anti-Cdh1 (DH01-DCS-266, ab3242,
Abcam, Cambridge, UK), and anti-c-myc (SC-40, Santa
Cruz). Horseradish peroxidase-conjugated goat anti-mouse
(115–035-146) and anti-rabbit (111-035-144) antibodies
were from Jackson Immuno Research Laboratories (West
Grove, PA). Alexa Fluor®-conjugated goat anti-rabbit and
goat anti-mouse IgG were from Molecular Probes/Thermo
Fisher Scientific (Eugene, OR). λ phosphatase (PO753S)
was from New England Biolabs (Ipswich, MI).

All experiments using mice were approved by the
Animal Care Committee of the University of Western
Ontario (Protocol No. 2015-021), in accordance with
regulations from the Canadian Council on Animal Care.
Primary mouse keratinocytes were isolated from skin
harvested from 2d-old CD-1 mice. Undifferentiated
keratinocytes were cultured in “Low Ca2+ medium”,
composed of Ca2+-free Eagle’s minimum essential
medium (06-174G, Lonza, Rockland, ME) supplemented
with growth additives and 8% fetal bovine serum
(FBS) pre-treated with Chelex resin, as described
[7, 13]. Keratinocyte differentiation was induced by
culture in growth medium supplemented with 1 mM
CaCl2 (“High-Ca2+ medium”) for intervals indicated in
individual experiments. Transfections were conducted
with polyethyleneimine (PEI), as described [43]. For
E2F1 turnover experiments, cycloheximide (CHX, 100
μg/ml, final) was added to keratinocyte cultures 24 h
after transfection and, where applicable, 30 min prior
to adjusting Ca2+ to 1.0 mM; cell lysates were prepared
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Plasmids

Waltham, MA). All photomicrographs shown are
representative of 3-5 experiments conducted on duplicate
samples, and using independent cell isolates.

The plasmids encoding V5-tagged wild type human
E2F1, E2F1 S403A, T433A and S403A/T433A mutants
have been described [12, 13]. All other mutant E2F1
plasmids were generated by site-directed mutagenesis and
PCR amplification, using the vector encoding V5-tagged
wild type E2F1 as a template. All vectors were verified
by dideoxy sequencing. The following plasmids were
obtained from Addgene (Cambridge MA): pRK5-HAUbiquitin-K11 (#22901), -K48 (#17605), -K63 (#17606)
and pRK5-HA-Ubiquitin-WT (#17608), originally
deposited by Drs. T. Dawson and C. Pickart, and pCMV2FLAG-tagged UBC13 (#12460), deposited by Dr. D.
Zhang. Mammalian expression vectors encoding hEmi1
and Cdh1 were generous gifts from Dr. P. K. Jackson
(Stanford University School of Medicine), and have been
previously described [36].

Statistical analysis
Data are expressed as mean + standard error, and
statistical analyses were conducted, as appropriate, with
one-way or two-way analysis of variance (ANOVA),
followed by Newman-Keuls or Bonferroni post-hoc test,
respectively. Statistical analyses were conducted with
GraphPad Prism Version 7 software, and significance was
set at P<0.05.

Abbreviations
APC/C, anaphase promoting complex/cyclosome;
CHX, cycloheximide; FBS, fetal bovine serum;
GAPDH, glyceraldehyde 3-phosphodehydrogenase;
HA, hemagglutinin; LMB, leptomycin B; NEM,
N-ethylmaleimide; NES, nuclear export sequence; PBS,
phosphate-buffered saline; SDS, sodium dodecylsulfate;
t½, half-life.

Immunoblot analysis and immunoprecipitation
Cell lysates were prepared with a modified RIPAlysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium
dodecylsulphate (SDS), 1 mM Na3VO4, 5 mM NaF, 1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml each aprotinin,
leupeptin and pepstatin). In experiments assessing
E2F1 ubiquitylation, the lysis buffer was supplemented
with 25 mM N-ethylmaleimide (NEM). Proteins in
lysates (30 μg/sample) were resolved by denaturing
polyacrylamide gel electrophoresis, transferred to
polyvinyledene fluoride membranes, which were probed
with antibodies indicated in individual experiments. For
immunoprecipitation assays, cell lysates (1.5 mg protein/
sample) were incubated with antibodies indicated in
individual experiments (3 μg/sample) for 16 h at 4°C.
The immune complexes were incubated with A/G
magnetic beads (88802, Pierce Biotechnology/Thermo
Fisher Scientific, Rockford, IL) for 1 h at 22°C, followed
by 5 washes with PBS containing 0.05% Tween-20,
and elution in 1x Laemmli sample buffer for 10 min at
25°C. Immune complexes were resolved and analysed
by immunoblot, as described above. The results shown
in figures are representative of 3-5 experiments, each
conducted with independent cell isolates.
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